Rafferty Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Sell |
2,199
-530
| -19% | -$55.3K | ﹤0.01% | 1027 |
|
|
2025
Q1 | $318K | Sell |
2,729
-901
| -25% | -$105K | ﹤0.01% | 949 |
|
|
2024
Q4 | $307K | Sell |
3,630
-1,054
| -23% | -$89.2K | ﹤0.01% | 1021 |
|
|
2024
Q3 | $421K | Sell |
4,684
-793
| -14% | -$71.3K | ﹤0.01% | 981 |
|
|
2024
Q2 | $441K | Sell |
5,477
-1,385
| -20% | -$111K | ﹤0.01% | 962 |
|
|
2024
Q1 | $548K | Buy |
6,862
+1,025
| +18% | +$81.8K | ﹤0.01% | 950 |
|
|
2023
Q4 | $465K | Buy |
5,837
+1,277
| +28% | +$102K | ﹤0.01% | 998 |
|
|
2023
Q3 | $319K | Buy |
4,560
+205
| +5% | +$14.3K | ﹤0.01% | 1011 |
|
|
2023
Q2 | $313K | Sell |
4,355
-158
| -4% | -$11.4K | ﹤0.01% | 1036 |
|
|
2023
Q1 | $278K | Buy |
4,513
+556
| +14% | +$34.3K | ﹤0.01% | 1055 |
|
|
2022
Q4 | $305K | Buy |
+3,957
| New | +$305K | ﹤0.01% | 1013 |
|
|
2022
Q3 | – | Sell |
-9,734
| Closed | -$373K | – | 1154 |
|
|
2022
Q2 | $373K | Buy |
9,734
+4,243
| +77% | +$163K | ﹤0.01% | 850 |
|
|
2022
Q1 | $227K | Sell |
5,491
-10,851
| -66% | -$449K | ﹤0.01% | 1129 |
|
|
2021
Q4 | $617K | Sell |
16,342
-1,076
| -6% | -$40.6K | ﹤0.01% | 1021 |
|
|
2021
Q3 | $574K | Buy |
17,418
+13,825
| +385% | +$456K | ﹤0.01% | 1011 |
|
|
2021
Q2 | $242K | Buy |
+3,593
| New | +$242K | ﹤0.01% | 1207 |
|
|
2021
Q1 | – | Sell |
-3,984
| Closed | -$325K | – | 1161 |
|
|
2020
Q4 | $325K | Sell |
3,984
-85
| -2% | -$6.93K | ﹤0.01% | 792 |
|
|
2020
Q3 | $290K | Sell |
4,069
-66
| -2% | -$4.7K | ﹤0.01% | 824 |
|
|
2020
Q2 | $340K | Buy |
+4,135
| New | +$340K | ﹤0.01% | 801 |
|
|
2020
Q1 | – | Sell |
-4,545
| Closed | -$470K | – | 617 |
|
|
2019
Q4 | $470K | Sell |
4,545
-8,285
| -65% | -$857K | 0.01% | 698 |
|
|
2019
Q3 | $260K | Buy |
+12,830
| New | +$260K | ﹤0.01% | 759 |
|